ArticleDiabetologia2023

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis.

Jedidiah I Morton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.